Membrane-cytoskeleton linker protein ezrin expression in renal cell carcinoma and its relation to tumor metastasis and tumor invasion

Yang Xu
2008-01-01
Abstract:AIM:To study the association of ezrin protein and ezrin mRNA expression level with the differentiation and metastasis of renal cell carcinoma. METHODS:Fifty cases of renal cell carcinoma and 40 cases of corresponding adjacent normal renal tissue were involved in the study. The expression of ezrin was compared using reverse transcriptase-polymerase chain reaction (RT-PCR),immunohistochemistry and Western Blot. RESULTS:The expression of ezrin was up-regulated in renal cell carcinoma tissue as compared with adjacent normal tissue.Immunohistochemistry revealed that ezrin protein expression and localization in the cell cytoplasm and membrane,and the expression of ezrin protein showed a significant difference between the renal cell carcinoma (96%,48/50) and the adjacent normal renal tissue (75%,30/40) (χ2=10.350,P=0.002); the positive rate of ezrin mRNA in renal cell carcinoma (82%,41/50) was significantly higher than that in the adjacent normal renal tissue (62.5%,25/40) (χ2=4.321,P=0.038). The mean weighted scores of ezrin immunostaining and the positive rate of ezrin mRNA in the group of lymph node metastasis were higher than those in the group of lymph node non-metastasis [(9.500±2.502) vs (7.232±3.045),13/14 vs 16/36,P0.05]; The mean weighted scores of ezrin immunostaining and the positive rate of Ezrin mRNA in the group of tumor thrombus of the inferior vena cava (IVC) were higher than those in no tumor thrombus of the IVC [(9.315±3.027) vs (7.563±2.991),14/14 vs 22/36,P0.05]. There was no correlation between the expression of ezrin at the protein,and mRNA levels and the age,gender,TNM stage,size,histological grade and histological subtype of renal cell carcinoma (P0.05). CONCLUSION:The expression of ezrin protein and mRNA in the renal cell carcinoma is up-regulated,and its degree is correlated with the status of lymph metastasis,tumor thrombus of the IVC. Ezrin may be involved in the occurrence,invasion and metastasis of renal cell carcinoma. Ezrin may serve as a marker for assessing the progression of renal cell carcinoma and provide assistance for clinical therapeutic decision.
What problem does this paper attempt to address?